Applied BioCode

Applied BioCode manufactures patented Barcoded Magnetic Beads (BMB), a digital multiplexing technology, for Molecular Diagnostic and Immunodiagnostic applications. The BMB-based BioCode MDx 3000 is a high throughput system that integrates and automates the PCR Amplification, Hybridization and Detection processes for multiplex infectious diseases panels in a 96-well plate format. Our Gastrointestinal Pathogen Panel identifies the 17 most pathogenic bacteria, viruses, and parasites. Applied BioCode provides custom multiplex solutions for both molecular and protein assay development. 4,096 BMB digital codes are available for a diverse range of bioassay applications. Applied BioCode offers comprehensive services and leading expertise in developmental guidance, testing, and feasibility to create robust, low-cost, and highly multiplexed assays. Our BMB technology is used worldwide for a diverse range of applications, including analysis of protein biomarkers, gene expression, pharmacogenomics, genetic analysis, HLA typing, agricultural genotyping, clinical diagnostics, and much more.
Type
Private
HQ
Santa Fe Springs, US
Founded
2008
Employees
23 (est)+5%
Applied BioCode was founded in 2008 and is headquartered in Santa Fe Springs, US

Key People at Applied BioCode

Winston Z. Ho

Winston Z. Ho

Founder and President
Michael Aye

Michael Aye

Vice President of Molecular Products for Molecular Diagnostics Program

Applied BioCode Locations

Santa Fe Springs, US

Applied BioCode Metrics

Applied BioCode Summary

Founding Date

2008

Total Funding

$17.5 M

Latest funding size

$9.26 M

Time since last funding

8 months
Applied BioCode's latest funding round of $9.26 M was in April 2016. In total, Applied BioCode has raised $17.5 M.
9.0% of current employees of Applied BioCode are female and 91.0% are male.

Applied BioCode News

Applied BioCode Company Life

You may also be interested in